Original news and analysis on international IP policy
The Indian fair trade regulator has dismissed a complaint against biopharmaceutical company Gilead Sciences that alleged the company engaged in anti-competitive activities in the licensing of its anti-HIV drugs, according to the SpicyIP blog.
Arusha, Tanzania – Pharmaceutical manufacturers in East Africa have joined forces to strengthen their production capacity to meet at least half of the region’s demand for affordable, quality medicines. The East African Community is supporting this ambitious goal through various initiatives, including a regional intellectual property policy to guide partner states on developing national legislation that fosters local pharmaceutical production.
Lyon, France – Biovision, a biennial international event on life sciences, brought together some 3,000 participants this week to discuss and compare experiences in different fields, including personalised medicine, how best to use natural resources and the impact of climate change on food security. Open innovation was presented as a way forward, and the role of companies in mitigation was deemed important but with ethics.
Lyon, France – Participants at a the Biovision international life sciences forum aimed at encouraging collaboration and integrating innovation shared experiences and discussed a number of topics including intellectual property strategy, technology transfer and the way forward for sustainable innovation.
The United States Congress on 21 March approved US$ 1.65 billion in aid and support for the Global Fund to Fight AIDS, Tuberculosis and Malaria, and US$ 4.07 billion for the US President’s Emergency Plan for AIDS Relief (PEPFAR). The Global Fund also announced a new Board chair and vice-chair.
The United States Supreme Court is scheduled to hear oral arguments on Monday in a case in which the US Federal Trade Commission is questioning payments made by brand name pharmaceutical companies to generic producers for delayed entry into the market of lower priced generics.
Lahore, Pakistan - Weak regulation of the local pharmaceutical industry in Pakistan, including non-enforcement of intellectual property rights and the absence of a simple and swift dispute resolution mechanism, have hit the country’s health sector badly, industry sources say.
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the International Federation of Red Cross and Red Crescent Societies (IFRC) announced on 19 March a two-year partnership on non-communicable diseases.
Tuberculosis is now a renewed threat, with strains that prove resistant to multiple drugs and are transmissible and the potential to spread widely, according to the World Health Organization and the Global Fund, which are looking for US$1.6 billion a year to prevent the spread of the disease.
Upwards of 50 civil society groups have issued a declaration asking for the exclusion of all forms of intellectual property rights from the upcoming Trans-Atlantic Free Trade Agreement between the European Union and the United States. They raised significant concerns about the potential effect of IP rights’ inclusion on the public interest in the countries involved.
Five United Nations agencies are joining efforts to tackle the rising issue of private standards which they say are affecting developing countries' exports by creating market entry hurdles for those countries. A new forum will be launched this week, and will establish its priority issues.
Dar es Salaam, Tanzania – The role of innovation as a driving force of social, economic, and environmental development is one of the central themes in post-2015 global development agenda discussions. In a ministerial-level meeting with guidance from the World Intellectual Property Organization last week, African policymakers outlined what they would need to foster innovation at home. Among a list of recommendations, ministers widely agreed on the importance of developing national intellectual property frameworks, capacity building, and raising awareness through education. Encouraging the use of IP flexibilities, however, was largely left out of the conversation.